CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 183 enrolled
Drug / intervention
Neurothrombectomydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03364023
NCT03364023N/ACompleted
CompareCT.gov

Post-Market Registry Of Stroke Patients Treated With Medtronic Neuro Thrombectomy Devices to Collect Real World Data in South East Asia (PROSPR-SEA)

Medtronic Neurovascular Clinical Affairs·observational·Posted Dec 6, 2017·Updated Aug 19, 2020

In Brief

An observational study evaluating Neurothrombectomy for Stroke, Acute. Completed, enrolled 183 participants across 10 sites in 3 countries.

Detailed Summary

The purpose of this post-market registry is to collect real-world data associated with the use of Medtronic market-released neurothrombectomy devices in acute ischemic stroke (AIS) patients from countries in South East Asia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Acute
CountriesSingapore, Thailand, Vietnam
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 6, 2017
Enrollment StartJan 1, 2018
Primary CompletionJul 2, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.6 years ago

Interventions

Neurothrombectomydevice

Medtronic Market-Released Neurothrombectomy Device